Voyager Limited Liability Company
John Connelly is our Vice President of Program and Alliance Management. Prior to Voyager, Mr. Connelly held positions of increasing responsibility at Genzyme Corporation, most recently as the Head of Program Management for Rare Diseases. In this role, Mr. Connelly led and/or managed a portfolio of projects ranging from preclinical to Phase 3 programs utilizing a multitude of therapeutic modalities including gene therapy. He started his program management career supporting the AAV gene therapy activities at Genzyme and thus brings to Voyager more than 15 years of experience managing gene therapy programs. Along with his leadership in program management, Mr. Connelly also played key roles in many of Genzyme’s strategic alliances. Mr. Connelly holds a Bachelors of Science in Biochemistry from the University of Vermont and a Masters of Business Administration from Suffolk University.